Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Natera (NTRA) and ISpecimen (ISPC)
TipRanksAug 1, 2023 09:01 ET
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and ISpecimen (ISPC)
TipRanksJul 6, 2023 09:10 ET
EF Hutton Trims ISpecimen's Price Target to $4.25 From $5.50, Maintains Buy Rating
MT NewswiresSep 23, 2022 11:13 ET
ISpecimen Analyst Ratings
Benzinga Analyst RatingsSep 23, 2022 10:53 ET
EF Hutton Maintains Buy on ISpecimen, Lowers Price Target to $4.25
Benzinga Real-time NewsSep 23, 2022 10:52 ET
No Data
No Data